Moderna mRNA flu shot wins FDA approval but awaits CDC recommendations
RegulatoryapprovedmFlusivaPositive
AI Analysis
Summary
Moderna's mFlusiva, an mRNA-based flu vaccine, has received FDA approval, becoming the first mRNA vaccine authorized in the US for flu prevention. The approval awaits CDC recommendations before market implementation.
Outcome Details
FDA approval for mRNA-based flu vaccine
Importance:9/10
Sentiment:
0.80
FDA approvalmRNA vaccineflu preventionfirst mRNA flu vaccine
Related Companies
Read the original article
Published by Pharmaceutical Technology on August 7, 2026 9:33 AM